Leflunomide. Arava, HWA 486, SU 101.
D000818:Animals; D004285:Dogs; D015507:Drugs, Investigational / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology; D007555:Isoxazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D000077339:Leflunomide; D016040:Lung Transplantation / Q000276:immunology; D051379:Mice; D051381:Rats; D016038:Skin Transplantation / Q000276:immunology
D015507:Drugs, Investigational; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide